In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device

Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2004.

Bibliographic Details
Main Author: Shawgo, Rebecca Scheidt, 1976-
Other Authors: Michael J. Cima.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2005
Subjects:
Online Access:http://hdl.handle.net/1721.1/17678
_version_ 1826196915238207488
author Shawgo, Rebecca Scheidt, 1976-
author2 Michael J. Cima.
author_facet Michael J. Cima.
Shawgo, Rebecca Scheidt, 1976-
author_sort Shawgo, Rebecca Scheidt, 1976-
collection MIT
description Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2004.
first_indexed 2024-09-23T10:39:58Z
format Thesis
id mit-1721.1/17678
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T10:39:58Z
publishDate 2005
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/176782019-04-10T14:18:24Z In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device Shawgo, Rebecca Scheidt, 1976- Michael J. Cima. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Materials Science and Engineering. Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2004. "June 2004." Includes bibliographical references. Temporal and spatial control over the delivery of therapeutic compounds is an important, fertile, and rapidly advancing field of study in medicine. This work describes the advancement of a new technology of drug delivery from a benchtop prototype releasing tracer molecules to an implantable device for initial animal studies. The improved MEMS (micro-electro-mechanical systems) device was used for the subcutaneous delivery of both tracer molecules (fluorescein and mannitol) and a chemotherapeutic agent (carmustine) in rats. Both temporal and spatial profiles of the tracer molecules were established; only the temporal kinetics of the carmustine were studied. The MEMS drug delivery device is based on a silicon substrate into which microreservoirs are etched. Each reservoir contains an individual dosage of drug and is independently addressable. The microreservoirs are covered with gold membranes which act as anodes. The application of an anodic voltage, in an aqueous solution containing chloride ions, electrochemically transforms gold into gold chloride which is readily soluble in water. This device allows the delivery of both solid and liquid drugs of a wide variety of compositions. (cont.) It is important to study the biocompatibility of the device activation process as well as that of the component materials since the activation of the MEMS drug delivery device depends on an electrochemical reaction. Other researchers have studied the biological response to gold, silicon, silicon dioxide and silicon nitride; however, few studies of the effect of voltage applications, particularly of gold electrochemistry, have ever been performed. The effects of both electrochemical dissolution of a macroscopic gold film electrode and the repeated electrochemical activation of gold MEMS microelectrodes on the immune response and fibrous capsule formation were observed, as well as the effect of long term implantation on gold electrochemistry. by Rebecca Scheidt Shawgo. Ph.D. 2005-06-02T18:13:30Z 2005-06-02T18:13:30Z 2004 Thesis http://hdl.handle.net/1721.1/17678 56029388 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 129 p. 5765301 bytes 5765108 bytes application/pdf application/pdf application/pdf Massachusetts Institute of Technology
spellingShingle Materials Science and Engineering.
Shawgo, Rebecca Scheidt, 1976-
In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title_full In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title_fullStr In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title_full_unstemmed In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title_short In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device
title_sort in vivo activation and biocompatibility of a mems microreservoir drug delivery device
topic Materials Science and Engineering.
url http://hdl.handle.net/1721.1/17678
work_keys_str_mv AT shawgorebeccascheidt1976 invivoactivationandbiocompatibilityofamemsmicroreservoirdrugdeliverydevice